From: Trends in anemia management in US hemodialysis patients 2004–2010
Time on dialysis | Incidence year | |||
---|---|---|---|---|
2004–2006 | 2007–2009 | 2010 | ||
Hemoglobin (g/dl), Median (Q25, Q75) | 0–3 month | 11.7 (10.4, 12.9) | 11.6 (10.3, 12.8) | 11.4 (10.0, 12.5) |
3–6 month | 12.3 (11.3, 13.2) | 12.3 (11.4, 13.0) | 12.0 (11.2, 12.7) | |
6–18 month | 12.1 (11.2, 12.9) | 11.9 (11.1, 12.7) | 11.8 (10.9, 12.5) | |
Percent with Hemoglobin <10 (monthly), Median (Q25, Q75) | 0–3 month | 12.8 (8.2, 30.4) | 13.3 (7.6, 34.0) | 17.1 (9.3, 42.8) |
3–6 month | 7.0 (6.6, 7.1) | 6.7 (6.5, 7.4) | 7.7 (6.6, 8.0) | |
6–18 month | 6.2 (6.0, 6.5) | 6.8 (6.5, 6.9) | 8.9 (8.3, 9.3) | |
Percent with Hemoglobin > 12 (monthly), Median (Q25, Q75) | 0–3 month | 42.0 (17.8, 57.1) | 40.6 (14.5, 57.4) | 33.6 (9.08, 49.5) |
3–6 month | 54.9 (50.5, 58.7) | 54.2 (49.8, 58.2) | 41.2 (35.8, 48.4) | |
6–18 month | 45.9 (44.6, 49.7) | 39.9 (36.9, 46.1) | 29.5 (25.7, 35.9) | |
Weekly ESA doses (Unit), Median (Q25, Q75) | 0–3 month | 18000 (9000, 30000) | 20000 (9000, 30600) | 18000 (8000, 30000) |
3–6 month | 12400 (4800, 24000) | 13500 (4800, 25200) | 10200 (2600, 21000) | |
6–18 month | 9100 (3900, 19500) | 9600 (3900, 20100) | 7800 (2400, 16800) | |
Percent of patients receiving monthly IV iron, Median (Q25, Q75) | 0–3 month | 71.1 (62.5,72.5) | 77.8 (67.9,78.5) | 76.0 (72.6,77.4) |
3–6 month | 71.0 (69.7,72.0) | 74.5 (73.6,76.2) | 70.3 (68.9,73.6) | |
6–18 month | 65.7 (64.5,68.2) | 67.4 (65.9,70.4) | 60.6 (58.1,62.2) | |
Monthly iron doses (mg) for those who had received iron, Median (Q25, Q75) | 0–3 month | 400 (200,800) | 475 (200,800) | 500 (300,850) |
3–6 month | 300 (200,500) | 300 (200,500) | 400 (200,600) | |
6–18 month | 200 (125,400) | 225 (125,400) | 300 (200,500) | |
TSat(%), Median (Q25, Q75) | 0–3 month | 18.4 (13.7, 24.8) | 18.3 (13.9, 24.5) | 21.5 (16.1, 28.4) |
3–6 month | 22.6 (17.0, 30.3) | 22.6 (17.2, 30.0) | 24.4 (19.1, 32.8) | |
6–18 month | 23.6 (18.3, 30.5) | 23.6 (18.4, 30.5) | 25.6 (20.3, 33.3) | |
Ferritin (ng/ml), Median (Q25, Q75) | 0–3 month | 284 (136, 533) | 312 (157, 566) | 354 (179, 624) |
3–6 month | 447 (243, 687) | 499 (287, 744) | 600 (360, 858) | |
6–18 month | 592 (376, 796) | 654 (436, 893) | 707 (474, 996) |